Table I.
Group | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 |
---|---|---|---|---|---|---|
Control | 46.16±3.28 | 42.19±4.09 | 37.33±2.1 | 30.27±4.02 | 21.09±5.52 | 16.31±4.92 |
APP/PS1 untreated | 56.2±2.94a | 54.33±9.91a | 50.27±4.32a | 42.72±6.73a | 38.94±5.15a | 38.22±6.94a |
APP/PS1 treated | 50.0±4.43b | 47.34±5.02b | 40.14±4.11b | 34.79±5.45b | 23.02±7.8b | 20.2±5.66b |
P<0.05, compared with the control group;
P<0.05, compared with the APP/PS1 untreated group.